WBH Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$328K Hold
2,080
– – 0.02% 307
2026
Q2
$329K Hold
2,080
– – 0.02% 307
2026
Q1
$267K Hold
2,080
– – 0.02% 316
2025
Q4
$254K Sell
2,080
-141
-6% -$16.2K 0.02% 312
2025
Q3
$223K Buy
+2,221
New +$200K 0.02% 328
2025
Q2
– Sell
-3,101
Closed -$251K – 354
2025
Q1
$251K Hold
3,101
– – 0.02% 293
2024
Q4
$279K Hold
3,101
– – 0.03% 275
2024
Q3
$306K Buy
+3,101
New +$305K 0.03% 262
2021
Q4
– Sell
-1,913
Closed -$241K – 316
2021
Q3
$241K Buy
1,913
+55
+3% +$7.08K 0.03% 268
2021
Q2
$231K Buy
1,858
+56
+3% +$7.36K 0.03% 251
2021
Q1
$244K Buy
1,802
+218
+14% +$32.6K 0.04% 247
2020
Q4
$244K Buy
+1,584
New +$203K 0.04% 236

Other funds holding XBI

WBH Advisory's XBI Position: Q3 2026 in Review

WBH Advisory held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 2,080 shares worth $328K. The position accounts for 0.02% of the portfolio, ranked #307.

WBH Advisory first reported a position in XBI in Q4 2020 and has held it in 12 quarters since. The position peaked at $329K in Q2 2026. 952 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • WBH Advisory held 2,080 shares of State Street SPDR S&P Biotech ETF worth $328K as of Q3 2026.
  • WBH Advisory left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.02% of WBH Advisory's portfolio in Q3 2026, its #307 holding.
  • WBH Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 12 quarters since.
  • WBH Advisory's State Street SPDR S&P Biotech ETF position peaked at $329K in Q2 2026.
  • 952 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on WBH Advisory's 13F filing for Q3 2026, filed 5 Nov 2026.